(Q35839058)
Statements
MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts (English)
N V Rajeshkumar
Elizabeth De Oliveira
Niki Ottenhof
James Watters
David Brooks
Tim Demuth
Stuart D Shumway
Shinji Mizuarai
Hiroshi Hirai
9 March 2011